(Q38379405)
Statements
1 reference
Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies (English)
1 reference
Karen A Tourian
1 reference
S Krishna Padmanabhan
1 reference
James Groark
1 reference
Claudine Brisard
1 reference
Deborah Farrington
1 reference
1 June 2009
1 reference
1 reference
31 Pt 1
1 reference
1405-1423
1 reference
Identifiers
1 reference
1 reference